Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 551,581 | 529,932 | 497,857 | 528,402 | 449,683 |
| Cost of Goods | 30,040 | 29,406 | 22,588 | 26,366 | 24,795 |
| Gross Profit | 521,541 | 500,526 | 475,269 | 502,036 | 424,888 |
| Operating Expenses | 387,265 | 402,320 | 401,787 | 420,427 | 394,564 |
| Operating Income | 134,316 | 98,612 | 74,070 | 81,975 | 31,119 |
| Interest Expense | 597 | 316 | 335 | 355 | 405 |
| Other Income | 14,300 | 10,375 | 30,362 | -10,903 | 262 |
| Pre-tax Income | 148,019 | 108,671 | 104,097 | 70,717 | 30,976 |
| Income Tax | 19,748 | 3,353 | 1,785 | 1,654 | 1,800 |
| Net Income Continuous | 128,271 | 105,318 | 102,312 | 69,063 | 29,176 |
| Net Income | $128,271 | $105,318 | $102,312 | $69,063 | $29,176 |
| EPS Basic Total Ops | 0.60 | 0.49 | 0.48 | 0.32 | 0.14 |
| EPS Basic Continuous Ops | 0.60 | 0.49 | 0.48 | 0.33 | 0.14 |
| EPS Diluted Total Ops | 0.59 | 0.48 | 0.47 | 0.32 | 0.14 |
| EPS Diluted Continuous Ops | 0.59 | 0.48 | 0.47 | 0.32 | 0.14 |
| EBITDA(a) | $148,178 | $112,047 | $87,961 | $96,201 | $44,937 |